BDTX
NASDAQ · Biotechnology
Black Diamond Therapeutics I
$2.26
+0.10 (+4.40%)
Open$2.23
Previous Close$2.16
Day High$2.29
Day Low$2.19
52W High$45.36
52W Low$23.71
Volume—
Avg Volume98.7K
Market Cap128.48M
P/E Ratio49.90
EPS$0.67
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+1,492.9% upside
Current
$2.26
$2.26
Target
$35.92
$35.92
$30.62
$35.92 avg
$44.24
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 26.85M | 24.30M | 27.99M |
| Net Income | 2.09M | 2.49M | 2.63M |
| Profit Margin | 7.8% | 10.3% | 9.4% |
| EBITDA | 3.87M | 3.57M | 4.44M |
| Free Cash Flow | 2.98M | 2.09M | 2.99M |
| Rev Growth | +10.3% | +9.4% | -7.6% |
| Debt/Equity | 0.41 | 0.35 | 0.43 |
Dividend
Dividend Yield2.19%
Annual Dividend$0.74
Payout Ratio95.0%
Frequencyquarterly
Ex-DividendMar 1, 2026
Pay DateMar 12, 2026
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |